We stratified the TCGA testicular cancer cohort into seminomas (SOX17+) and non-seminomas (SOX2+ (EC), AFP+ (yolk-sac tumor), beta-hCG+ (choriocarcinomas) (Figure S1D). The gene discussed is SOX2; the disease is choriocarcinoma.